{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:39:48Z","timestamp":1757608788672,"version":"3.44.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1986,3]]},"DOI":"10.1016\/0002-9343(86)90741-2","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T16:57:06Z","timestamp":1086195426000},"page":"545-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nephrotic-range proteinuria and hyperglycemia associated with clonidine therapy"],"prefix":"10.1016","volume":"80","author":[{"given":"John","family":"Josselson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(86)90741-2_BIB1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(71)90031-8","article-title":"The central hyperglycemic effect of clonidine","volume":"16","author":"Bock","year":"1971","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/0002-9343(86)90741-2_BIB2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1254\/jjp.19.249","article-title":"Hyperglycemic action of 2-(2,6-dichlorophenylamine)-2-imadazole hydrochloride in relation to its hypertensive effect","volume":"19","author":"Iwata","year":"1969","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/0002-9343(86)90741-2_BIB3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/clpt.1983.239","article-title":"Clonidine in patients with diabetes and mild hypertension","volume":"34","author":"Guthrie","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/0002-9343(86)90741-2_BIB4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/diab.27.5.554","article-title":"Induction of defective insulin secretion and impaired glucose tolerance by clonidine","volume":"27","author":"Metz","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/0002-9343(86)90741-2_BIB5","first-page":"280","article-title":"Effects of clonidine and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients","volume":"13","author":"Snug","year":"1971","journal-title":"Curr Ther Res"},{"key":"10.1016\/0002-9343(86)90741-2_BIB6","series-title":"Hochdruck therapie: symposium \u00fcber 2-(2,6-dichloro-phenylamine)-2-imidazolin-hydrochlorid","first-page":"150","article-title":"The effect of Catapres on the intravenous glucose tolerance test","author":"Wahl","year":"1968"},{"key":"10.1016\/0002-9343(86)90741-2_BIB7","first-page":"325","article-title":"Clonidine and glucose intolerance","volume":"16","author":"Webster","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/0002-9343(86)90741-2_BIB8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-75-2-239","article-title":"Diabetic glomerulosclerosis in the absence of glucose intolerance","volume":"75","author":"Strauss","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-9343(86)90741-2_BIB9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1172\/JCI105765","article-title":"Observations on the mechanisms of glucosuria during glucose loads in normal and nondiabetic subjects","volume":"47","author":"McPhaul","year":"1968","journal-title":"J Clin Invest"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934386907412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934386907412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:17:03Z","timestamp":1756883823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002934386907412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,3]]}},"alternative-id":["0002934386907412"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(86)90741-2","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[1986,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrotic-range proteinuria and hyperglycemia associated with clonidine therapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(86)90741-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1986 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}